Current research toward optimizing dosing of first-line antituberculosis treatment

Por McIlleron, Helen, Chirehwa, Maxwell T
Publicado no Expert Rev Anti Infect Ther (2018)

Quantitative assessment of the activity of antituberculosis drugs and regimens

Por Chirehwa, Maxwell T., Velásquez, Gustavo E., Gumbo, Tawanda, McIlleron, Helen
Publicado no Expert Rev Anti Infect Ther (2019)

Use of the ‘Accountability for Reasonableness’ Approach to Improve Fairness in Accessing Dialysis in a Middle-Income Country

Por Moosa, Mohammed Rafique, Maree, Jonathan David, Chirehwa, Maxwell T., Benatar, Solomon R.
Publicado no PLoS One (2016)

Correction: Use of the 'Accountability for Reasonableness' Approach to Improve Fairness in Accessing Dialysis in a Middle-Income Country

Por Moosa, Mohammed Rafique, Maree, Jonathan David, Chirehwa, Maxwell T., Benatar, Solomon R.
Publicado no PLoS One (2016)

Quality of abstracts of pilot trials in heart failure: A protocol for a systematic survey

Por Isiguzo, Godsent, Zunza, Moleen, Chirehwa, Maxwell, Mayosi, Bongani M., Thabane, Lehana
Publicado no Contemp Clin Trials Commun (2017)

Renal abnormalities among HIV-infected, antiretroviral naive children, Harare, Zimbabwe: a cross-sectional study

Por Dondo, Vongai, Mujuru, Hilda A, Nathoo, Kusum J, Chirehwa, Maxwell, Mufandaedza, Zivanai
Publicado em 2013

Quality of pilot trial abstracts in heart failure is suboptimal: a systematic survey

Por Isiguzo, Godsent C., Zunza, Moleen, Chirehwa, Maxwell, Mayosi, Bongani M., Thabane, Lehana
Publicado no Pilot Feasibility Stud (2018)

Model-Based Evaluation of Higher Doses of Rifampin Using a Semimechanistic Model Incorporating Autoinduction and Saturation of Hepatic Extraction

Por Chirehwa, Maxwell T., Rustomjee, Roxana, Mthiyane, Thuli, Onyebujoh, Philip, Smith, Peter, McIlleron, Helen, Denti, Paolo
Publicado no Antimicrob Agents Chemother (2015)

Erratum for Chirehwa et al., Model-Based Evaluation of Higher Doses of Rifampin Using a Semimechanistic Model Incorporating Autoinduction and Saturation of Hepatic Extraction

Por Chirehwa, Maxwell T., Rustomjee, Roxana, Mthiyane, Thuli, Onyebujoh, Philip, Smith, Peter, McIlleron, Helen, Denti, Paolo
Publicado no Antimicrob Agents Chemother (2016)

Pharmacokinetics of Pyrazinamide and Optimal Dosing Regimens for Drug-Sensitive and -Resistant Tuberculosis

Por Chirehwa, Maxwell T., McIlleron, Helen, Rustomjee, Roxana, Mthiyane, Thuli, Onyebujoh, Philip, Smith, Peter, Denti, Paolo
Publicado no Antimicrob Agents Chemother (2017)

Assessment of quality of obstetric care in Zimbabwe using the standard primipara

Por Guzha, Bothwell Takaingofa, Magwali, Thulani Lesley, Mateveke, Bismark, Chirehwa, Maxwell, Nyandoro, George, Munjanja, Stephen Peter
Publicado no BMC Pregnancy Childbirth (2018)

HIV-1 Coinfection Does Not Reduce Exposure to Rifampin, Isoniazid, and Pyrazinamide in South African Tuberculosis Outpatients

Por Rockwood, Neesha, Meintjes, Graeme, Chirehwa, Maxwell, Wiesner, Lubbe, McIlleron, Helen, Wilkinson, Robert J., Denti, Paolo
Publicado no Antimicrob Agents Chemother (2016)

Effect of efavirenz-based antiretroviral therapy and high-dose rifampicin on the pharmacokinetics of isoniazid and acetyl-isoniazid

Por Chirehwa, Maxwell T, McIlleron, Helen, Wiesner, Lubbe, Affolabi, Dissou, Bah-Sow, Oumou, Merle, Corinne, Denti, Paolo
Publicado no J Antimicrob Chemother (2019)

Pharmacokinetics and other risk factors for kanamycin-induced hearing loss in patients with multi-drug resistant tuberculosis

Por Ghafari, Nazanin, Court, Richard, Chirehwa, Maxwell Tawanda, Wiesner, Lubbe, Petersen, Lucretia, Maartens, Gary, Gumbo, Tawanda, McIlleron, Helen, Ramma, Lebogang
Publicado no Int J Audiol (2019)

Effect of rifampicin and efavirenz on moxifloxacin concentrations when co-administered in patients with drug-susceptible TB

Por Naidoo, Anushka, Chirehwa, Maxwell, McIlleron, Helen, Naidoo, Kogieleum, Essack, Sabiha, Yende-Zuma, Nonhlanhla, Kimba-Phongi, Eddy, Adamson, John, Govender, Katya, Padayatchi, Nesri, Denti, Paolo
Publicado no J Antimicrob Chemother (2017)

Population Pharmacokinetics of Cycloserine and Pharmacokinetic/Pharmacodynamic Target Attainment in Multidrug-Resistant Tuberculosis Patients Dosed with Terizidone

Por Chirehwa, Maxwell T., Court, Richard, de Kock, Mariana, Wiesner, Lubbe, de Vries, Nihal, Harding, Joseph, Gumbo, Tawanda, Maartens, Gary, Warren, Rob, Denti, Paolo, McIlleron, Helen
Publicado no Antimicrob Agents Chemother (2020)

Effect of genetic variation in UGT1A and ABCB1 on moxifloxacin pharmacokinetics in South African patients with tuberculosis

Por Naidoo, Anushka, Ramsuran, Veron, Chirehwa, Maxwell, Denti, Paolo, McIlleron, Helen, Naidoo, Kogieleum, Yende-Zuma, Nonhlanhla, Singh, Ravesh, Ngcapu, Sinaye, Chaudhry, Mamoonah, Pepper, Michael S, Padayatchi, Nesri
Publicado no Pharmacogenomics (2018)

Effects of genetic variability on rifampicin and isoniazid pharmacokinetics in South African patients with recurrent tuberculosis

Por Naidoo, Anushka, Chirehwa, Maxwell, Ramsuran, Veron, McIlleron, Helen, Naidoo, Kogieleum, Yende-Zuma, Nonhlanhla, Singh, Ravesh, Ncgapu, Sinaye, Adamson, John, Govender, Katya, Denti, Paolo, Padayatchi, Nesri
Publicado no Pharmacogenomics (2019)

Early antituberculosis drug exposure in hospitalized patients with human immunodeficiency virus‐associated tuberculosis

Por Schutz, Charlotte, Chirehwa, Maxwell, Barr, David, Ward, Amy, Janssen, Saskia, Burton, Rosie, Wilkinson, Robert J., Shey, Muki, Wiesner, Lubbe, Denti, Paolo, McIlleron, Helen, Maartens, Gary, Meintjes, Graeme
Publicado no Br J Clin Pharmacol (2020)

Low Antituberculosis Drug Concentrations in HIV-Tuberculosis-Coinfected Adults with Low Body Weight: Is It Time To Update Dosing Guidelines?

Por Sekaggya-Wiltshire, Christine, Chirehwa, Maxwell, Musaazi, Joseph, von Braun, Amrei, Buzibye, Allan, Muller, Daniel, Gutteck, Ursula, Motta, Ilaria, Calcagno, Andrea, Fehr, Jan S., Kambugu, Andrew, Castelnuovo, Barbara, Lamorde, Mohammed, Denti, Paolo
Publicado no Antimicrob Agents Chemother (2019)